Press Release

Oct 25, 2018

Fullerton Health China Closes Investment in Redleaf Hospital, Accelerating its Growth in China’s Sophisticated Healthcare Market

Shanghai, October 25, 2018 – Fullerton Healthcare Corporation Limited (“Fullerton Health” or the “Group”), a leading vertically integrated healthcare platform in Asia Pacific, announced today that Fullerton Health China Limited (“Fullerton China”) has completed an equity investment of RMB300 million in Shanghai Redleaf International Women’s & Children’s Hospital (“Redleaf Hospital”). This is Fullerton China’s first investment in the specialty hospitals sector, following which Fullerton China will become a key strategic shareholder of Redleaf Hospital.

 

The investment in Redleaf Hospital is an important step that demonstrates Fullerton China’s commitment to the domestic healthcare market. In May 2018, Fullerton China acquired a majority stake in Jiangsu Kangruijia Medical Investment Management Co., Ltd (“Global Doctor”), a leading primary care clinic group in China with healthcare services network of eighteen clinics.

 

This strategic investment from Fullerton China provides Redleaf Hospital with an even stronger platform for future growth. Redleaf Hospital, which currently focuses on pediatrics, obstetrics and gynecology, will expand into a multi-specialty hospital covering other specialties such as orthopedics and ophthalmology. Fullerton Health and Fullerton China will leverage their deep sector expertise, established over years of operating professional healthcare institutions across the Asia Pacific region, to guide the successful implementation of Redleaf Hospital’s expansion plan. A new upgraded hospital is expected to open at the end of 2019.

 

Additionally, Fullerton China and Redleaf Hospital also plan to jointly invest RMB200 million to set up a chain of primary care clinics in Shanghai. Through leveraging Fullerton Health’s resources and expertise in healthcare centre operation and management, the clinics will provide GP, specialist outpatient, health screening and other services, which are consistent with the Chinese government’s plans to establish an effective and multi-tiered healthcare system in the country.

 

David Sin, Deputy Chairman of Fullerton Health, commented: “As one of China's leading women’s and children’s healthcare institutions, Redleaf Hospital has a strong reputation among clients, healthcare professionals and the broader industry. We are extremely excited to partner with Redleaf Hospital as Fullerton Health accelerates its expansion in the Chinese market. China is focused on the development of a diversified healthcare system and there is increasing demand from the public for quality healthcare services. Against this backdrop, Fullerton China’s strategic investment in Redleaf Hospital comes at an important moment. The strategy and strengths of both sides are highly complementary, and we will aim to provide patients with higher quality, more efficient and more accessible healthcare services."

 

Ma Xuanhua, Chairperson of Redleaf Hospital, said: "We warmly welcome Fullerton China's investment into Redleaf Hospital. Over the years, we have earned an excellent reputation in the industry through our professional services, as well as our solid patient base and strong medical team. The investment from Fullerton China will inject new growth and lead to a brighter future for Redleaf Hospital. We look forward to working with Fullerton China to expand our capabilities and to provide more comprehensive, more sophisticated, healthcare solutions to benefit a greater number of patients in the Shanghai metropolitan area."

 

Since its entry into the Chinese market in 2017, Fullerton Health has secured a substantial investment from Ping An Capital Co., Ltd and completed the acquisition of a majority stake in Global Doctor in May 2018.         

 

- End – 

 

富乐中国完成入股上海红枫医院  加快深耕中国私立医疗市场

 

上海,2018年10月25日——亚太区领先的综合健康解决方案提供商富乐医疗集团(“富乐医疗”或“集团”)今日宣布,富乐医疗中国有限公司(”富乐中国”)已经完成对上海红枫国际妇儿医院(“红枫医院”)3亿元人民币的股权投资。这是富乐中国在专科医院领域的第一笔投资,富乐中国将成为红枫医院的重要战略投资者。

此次投资又一次显示了富乐中国深耕中国私立医疗市场的决心。2018年5月,富乐中国曾通过股权投资成为江苏康瑞家医疗投资管理有限公司(“环球医生”)的控股股东。环球医生是中国领先的初级诊疗服务提供商之一,其医疗网络包括18家诊所。

富乐中国的入股将助力红枫医院面向未来、加快发展。目前专注妇幼医疗的红枫医院,将逐步发展为提供包括骨科和眼科等服务在内的综合性医院。富乐医疗集团及富乐中国将充分发挥其在亚太地区运营专业医疗服务机构的经验,帮助红枫医院成功实现发展规划。新医院预计在2019年年底开始运营。

此外,富乐中国与红枫医院还计划共同出资2亿元人民币,于上海开设初级诊疗连锁诊所,充分利用富乐医疗集团在医疗中心运营管理方面的资源与专业经验,提供包括全科诊疗、专科门诊、健康检查等在内的医疗服务,支持中国政府建立高效分级诊疗体系的目标。

富乐医疗集团副董事长辛大伟 (David Sin) 先生表示:“作为中国领先的妇儿医疗服务机构之一,红枫医院在用户群体、专业人士和业界享有盛誉。在富乐医疗加快深耕中国市场之际,我们对于与红枫医院携手倍感振奋。在中国鼓励发展多元化医疗体系,且民众对于医疗服务质量要求日益增强的大趋势下,富乐集团和红枫医院的战略合作正当其时。双方战略高度契合,优势深度互补,我们将致力于为患者提供更优质、高效和便捷的医疗健康服务。”

红枫医院董事长马绚华女士表示:“我们热烈欢迎富乐中国对红枫医院的投资。多年来,通过专业的服务、稳固的客户基础以及强大的医疗专业团队,红枫医院在业内树立了良好的口碑。富乐中国的加入为红枫医院注入了新的发展动力,红枫的前景将更加广阔。我们期待和富乐中国联手,吸引更多专业人才,提供更为全面的医疗服务,造福位于以上海为中心的长三角地区更广泛的客户群体。“

自2017年进入中国市场以来,富乐医疗已经获得平安资本重大投资,并于2018年5月完成对环球医生的控股股权的收购。                                                                       

 

-   结束   -

 

About Fullerton Health 

Fullerton Health is a leading vertically integrated healthcare platform in the Asia Pacific region. Founded in Singapore in 2011, today they serve clients through over 500 healthcare facilities and a large global network of healthcare providers across eight markets in Asia. Fullerton Health’s value proposition is the integration of healthcare service offerings with customized management and advisory capabilities, in line with its mission to transform Asian healthcare and make it affordable and accessible for the patients.

For more information on Fullerton Health, please visit http://www.fullertonhealth.com/.

 

About Shanghai Redleaf International Women’s & Children’s Hospital

Founded in 2011, Shanghai Redleaf International Women’s & Children’s Hospital, is a leading private hospital that provides comprehensive, quality healthcare and consultation services for women and children in Shanghai with its international and professional medical staff. Redleaf prides itself on being the first comprehensive international-standard women's hospital in China.

For more information on Redleaf Hospital, please visit http://www.redleafhospital.com/index/main.

 

关于富乐医疗

富乐医疗集团是亚太地区领先的综合健康解决方案提供商,于2011年在新加坡成立,目前在亚太区8个国家和地区通过超过500家医疗中心和庞大的跨国医疗健康服务供应商网络为客户提供服务。富乐医疗一直致力对医疗服务进行垂直整合,通过提供定制化管理和咨询建议,提升亚洲医疗健康服务水平,为企业客户提供便捷、优质且价格合理的医疗健康服务。

欲了解更多富乐医疗有关信息,请访问官方网站  http://www.fullertonhealth.com/。

 

关于红枫医院             

上海红枫国际妇儿医院成立于2011年,是上海首家具备国际化水准的私立妇儿医院。红枫医院汇聚了高度国际化和专业化的医疗团队,为女性和儿童客户提供全面、优质的医疗及诊疗服务。

欲了解更多红枫医院有关信息,请访问官方网站http://www.redleafhospital.com/index/main。